| [1] |
Hamanaka RB, Chandel NS. Targeting glucose metabolism for cancer therapy[J].J Exp Med,2012,209(2):211-215.
|
| [2] |
Airley RE,Mobasheri A.Hypoxic regulation of glucose transport,anaerobic metabolism and angiogenesis in cancer:novel pathways and targets for anticancer therapeutics[J].Chemotherapy,2007,53(4):233-256.
|
| [3] |
Macheda ML,Rogers S,Best JD.Molecular and cellular regulation of glucose transporter(GLUT)proteins in cancer[J].J Cell Physiol,2005,202(3):654-662.
|
| [4] |
Chan DA,Sutphin PD,Nguyen P,et al.Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality[J].Sci Transl Med,2011,3(94):70-94.
|
| [5] |
Robey RB,Hay N.Mitochondrial hexokinases,novel mediators of the antiapoptotic effects of growth factors and Akt[J].Oncogene,2006,25(34):4683-4696.
|
| [6] |
Jae HJ,Chung JW,Park HS,et al.The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate:in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model[J].Korean J Radiol,2009,10(6):596-603.
|
| [7] |
Kim JW,Gao P,Liu YC,et al.Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1[J].Mol Cell Biol,2007,27(21):7381-7393.
|
| [8] |
Dang CV,Lewis BC,Dolde C,et al.Oncogenes in tumor metabolism,tumorigenesis,and apoptosis[J].J Bioenerg Biomembr,1997,29(4):345-354.
|
| [9] |
Pelicano H, Martin DS, Xu RH, et al. Glycolysis inhibition for anticancer treatment[J].Oncogene,2006,25(34):4633-4646.
|
| [10] |
Yang L,You QD,Yan Y,et al.Research advances in wogonin′s anti-tumor effects[J].J China Pharm Univ(中国药科大学学报),2009,40(6):576-579.
|
| [11] |
Gao Y,Zhao Y,Yao J,et al.Wogonin suppresses human alveolar adenocarcinoma cell A549 invasion and metastasis induced by IL-6[J].J China Pharm Univ(中国药科大学学报),2014,45(4):456-164.
|
| [12] |
Jose C,Bellance N,Rossignol R.Choosing between glycolysis and oxidative phosphorylation:a tumor′s dilemma[J]? Bba-Bioenergetics,2011,1807(6):552-561.
|
| [13] |
Zhao K,Wei L,Hui H,et al.Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways[J].PLoS One,2014,9(9):e106458.
|
| [14] |
Song X,Yao J,Wang F,et al.Wogonin inhibits tumor angiogenesis via degradation of HIF-1alpha protein[J].Toxicol Appl Pharmacol,2013,271(2):144-155.
|
| [15] |
Yao J,Zhao L,Zhao Q,et al.NF-kappaB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis[J].Cell Death Dis,2014,5:e1283.
|
| [16] |
Wang H,Zhao L,Zhu LT,et al.Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1alpha and glycolysis,by inhibiting PI3K/Akt signaling pathway[J].Mol Carcinog,2014,53(Suppl 1):E107-118.
|
| [17] |
Yang H,Hui H,Wang Q,et al.Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells[J].Oncotarget,2014,5(18):8188-8201.
|
下载:
